LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Radicicol | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1007 | 3769 | 0.2673 | -0.0335 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2834 | 3769 | 0.7518 | 0.6499 |
BT-20 | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3857 | 3769 | 1.0232 | 1.0327 |
BT-20 | XL147 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3318 | 3769 | 0.8803 | 0.8312 |
BT-20 | Saracatinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2338 | 3769 | 0.6203 | 0.4644 |
BT-20 | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3360 | 3769 | 0.8915 | 0.8470 |
BT-20 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2310 | 3769 | 0.6128 | 0.4538 |
BT-20 | Sorafenib | 3.33 | uM | LJP6 | 72 | hr | 1097 | 3110 | 3769 | 0.8252 | 0.7534 |
BT-20 | SU11274 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3273 | 3769 | 0.8685 | 0.8144 |
BT-20 | Fedratinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2597 | 3769 | 0.6891 | 0.5615 |
BT-20 | TGX221 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 4159 | 3769 | 1.1033 | 1.1457 |
BT-20 | Torin1 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 791 | 3769 | 0.2098 | -0.1146 |
BT-20 | Torin2 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 644 | 3769 | 0.1708 | -0.1696 |
BT-20 | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 1215 | 3769 | 0.3224 | 0.0442 |
BT-20 | Trametinib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2749 | 3769 | 0.7294 | 0.6184 |
BT-20 | TWS119 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2542 | 3769 | 0.6745 | 0.5409 |
BT-20 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1097 | 3335 | 3769 | 0.8848 | 0.8375 |
BT-20 | Withaferin A | 3.33 | uM | LJP5 | 72 | hr | 1097 | 568 | 3769 | 0.1509 | -0.1978 |
BT-20 | Withaferin A | 3.33 | uM | LJP6 | 72 | hr | 1097 | 535 | 3769 | 0.1421 | -0.2102 |
BT-20 | WYE-125132 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1166 | 3769 | 0.3095 | 0.0260 |
BT-20 | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 721 | 3769 | 0.1913 | -0.1408 |
BT-20 | XMD11-50 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2057 | 3769 | 0.5459 | 0.3594 |
BT-20 | Y39983 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 2903 | 3769 | 0.7702 | 0.6759 |
BT-20 | YM 201636 | 3.33 | uM | LJP5 | 72 | hr | 1097 | 2295 | 3769 | 0.6088 | 0.4482 |
BT-20 | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 1097 | 1050 | 3769 | 0.2786 | -0.0176 |